5 Visits vs. 3 Visits: The Multi-Injection Debate
Supartz and Synvisc are both multi-injection HA protocols, but they differ significantly in how many shots you need, what molecular weight they deliver, and whether the HA is cross-linked. If your doctor has recommended a multi-injection HA series, understanding these differences helps you pick the right one.
Supartz FX (the current formulation) uses a 3-5 injection protocol with medium molecular weight, non-cross-linked HA. Synvisc uses a 3-injection protocol with very high molecular weight, cross-linked HA. Both are avian-derived and Medicare-covered.
Quick Comparison Table
| Feature | Supartz FX | Synvisc |
|---|---|---|
| Manufacturer | Bioventus (orig. Seikagaku) | Sanofi |
| Injections | 3-5 weekly | 3 weekly |
| Volume per injection | 2.5 mL | 2 mL |
| Total volume | 7.5-12.5 mL | 6 mL |
| Molecular weight | Medium (620-1,170 kDa) | Very high (6 million Da) |
| Cross-linked | No | Yes (hylan G-F 20) |
| Source | Avian | Avian |
| Bird allergy safe | No | No |
| FDA approval | 2001 | 1997 |
| HCPCS Code | J7321 | J7325 |
| Self-pay | $600-$1,000 | $700-$1,000 |
| Duration | Up to 6 months | Up to 6 months |
| Medicare covered | Yes | Yes |
What Is Supartz FX?
Supartz FX is a non-cross-linked, medium molecular weight HA originally developed by Seikagaku Corporation in Japan. The “FX” reformulation allows doctors to choose between 3 and 5 weekly injections. It has been a staple of the US viscosupplementation market since 2001.
Supartz Advantages
What Is Synvisc?
Synvisc contains hylan G-F 20, a cross-linked HA with the highest molecular weight of any multi-injection product. It was one of the first two HA products FDA-approved in the US in 1997 and remains widely recognized.
Synvisc Advantages
Cross-Linked vs. Non-Cross-Linked
This is the key formulation difference between these two products:
Supartz FX (Non-Cross-Linked)
- HA in natural molecular state
- Broken down faster but replaced by frequent doses
- Lower risk of pseudoseptic reactions
- Delivers more total HA (volume compensates)
- Easier for doctors to inject (thinner)
Synvisc (Cross-Linked)
- Chemically bonded hylan polymer
- Resists breakdown, stays in joint longer
- Very high viscosity and elasticity
- Needs fewer doses but slightly higher reaction risk
- Thicker gel, requires skilled injection technique
Cost Breakdown
| Factor | Supartz FX (3-shot) | Supartz (5-shot) | Synvisc |
|---|---|---|---|
| Drug cost | $600-$800 | $800-$1,000 | $700-$1,000 |
| Office copays | $75-$150 | $125-$250 | $75-$150 |
| Total (self-pay) | $675-$950 | $925-$1,250 | $775-$1,150 |
| Total (Medicare) | $150-$300 | $200-$400 | $150-$300 |
Key finding: The 3-shot Supartz FX and 3-shot Synvisc protocols are very similar in total cost. The 5-shot Supartz protocol costs more due to extra office visits.
Making Your Decision
Choose Supartz FX if:
- You prefer non-cross-linked, natural HA
- You want more total HA volume delivered
- Cost is a primary concern (3-shot is cheapest option)
- You are concerned about inflammatory reactions from cross-linked products
- Your provider has strong Supartz experience
Choose Synvisc if:
- You want the highest molecular weight available in a series
- You prefer the longest established track record (since 1997)
- You may want to upgrade to Synvisc-One later
- Your doctor has extensive Synvisc experience
- You like the idea of cross-linked durability
Frequently Asked Questions
Is Supartz or Synvisc more effective?
Clinical studies show comparable outcomes. Neither has demonstrated consistent superiority. The higher molecular weight of Synvisc has not been proven to produce better clinical results.
Does the Supartz FX 3-shot protocol work as well as the 5-shot?
Yes. Clinical data supports the 3-injection protocol as equivalent to the original 5-injection version in terms of pain relief and duration.
Can I switch from Supartz to Synvisc?
Yes. Switching between products is safe and common. Some patients try both to see which provides better individual results.
Both require allergy screening, right?
Yes. Both are avian-derived. If you have egg, chicken, or feather allergies, neither is safe. Consider Euflexxa or Durolane instead.
Which is better for repeat treatments over years?
Both can be repeated every 6 months. Some physicians prefer non-cross-linked products (Supartz) for long-term repeated use due to the lower reaction risk profile, but Synvisc also has a good long-term safety record.
The Bottom Line
Supartz FX delivers more HA with natural structure at a lower price. Synvisc provides the highest MW in fewer visits with cross-linked durability.
Both provide similar duration of relief and clinical outcomes. The choice comes down to:
- Formulation philosophy: Non-cross-linked (Supartz) vs. cross-linked (Synvisc)
- Volume preference: More total HA (Supartz) vs. higher MW per mL (Synvisc)
- Cost and convenience: Very similar for 3-shot protocols
Talk to your provider about which approach they recommend for your situation.
Find Multi-Injection HA Providers
Connect with specialists offering Supartz, Synvisc, and other viscosupplementation options.
Your information is secure. See our Privacy Policy and Terms of Service.
Thank You!
We've received your request. A provider specialist will contact you within 1-2 business days to help you find the right care.
What happens next?
- 1 We'll verify your insurance coverage
- 2 Match you with quality providers in your area
- 3 Contact you to discuss your options
Questions? Browse our guides:
How to Choose a ProviderRelated Comparisons
HA Treatment Updates
Stay informed about knee osteoarthritis treatment options.
Join 10,000+ readers. No spam.